We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

WEX:NYSEWEX Inc. Analysis

Data as of 2026-09-01 - not real-time

$190.58

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

WEX Inc. is priced at $190.58 and its moving averages line up in bullish order, the shorter sitting above the longer. Over a rolling month the price has gained 16.0%. Relative strength is 53.5 — neutral — and the MACD signal is bearish. Recent trading has carved out support near $181.87 and resistance around $203.99.
Multiples put this in fair territory: 19.7 times earnings against the sector's 35.8. Revenue is growing at 14.2% on a 12.6% profit margin.
The composite risk read is 6/10, putting it in elevated territory. With 30-day volatility of 42.0%, a beta of 0.51 and a maximum drawdown of 31.4%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Short, medium and long-term reads agree on buy, with conviction of 5/10.

Top Market Events

Payment solutions provider WEX NYSE:WEX reported Q2 CY2026 results topping the market’s revenue expectations, with...Updated Jul 22, 2026 0 PORTLAND, Maine-- BUSINESS WIRE --Jul 22, 2026-- WEX NYSE: WEX , a global leader in intelligent...Payment solutions provider WEX NYSE:WEX reported Q2 CY2026 results , with sales up 14.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 5/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 156.89
  • MACD momentum is negative

Medium Term

1–3 years
Positive
Model confidence: 5/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 19.7 versus sector average of 35.8
  • Trading above the 200-day average of 156.89

Long Term

> 3 years
Positive
Model confidence: 5/10

Key Factors

  • P/E of 19.7 versus sector average of 35.8
  • Revenue growth of +14.2%
  • Return on equity of 30.2%

Key Metrics & Analysis

Financial Health

Revenue Growth14.20%
Profit Margin12.56%
P/E Ratio19.7
ROE30.19%
ROA2.89%
Debt/Equity398.42
P/B Ratio4.9
Op. Cash Flow$262.9M
Free Cash Flow$1.3B
Industry P/E35.8

Technical Analysis

TrendBullish
RSI53.5
Support$181.87
Resistance$203.99
MA 20$193.02
MA 50$170.71
MA 200$156.89
MACDBearish
VolumeDecreasing
Fear & Greed Index94.79

Valuation

Fair Value$918.51
Target Price$192.40
Upside/Downside0.95%
GradeFair
TypeGrowth

Risk Assessment

Beta0.51
Volatility42.03%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.